Last reviewed · How we verify
Dexmedetomidine 1μg／kg
Dexmedetomidine 1μg／kg is a Small molecule drug developed by Eye & ENT Hospital of Fudan University. It is currently FDA-approved. Also known as: Dexmedetomidine Hydrochloride Injection.
Dexmedetomidine 1μg/kg, developed by the Eye & ENT Hospital of Fudan University, is a marketed drug with a key composition patent expiring in 2028. The drug's primary strength lies in its established market presence, supported by its current revenue generation. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | Dexmedetomidine 1μg／kg |
|---|---|
| Also known as | Dexmedetomidine Hydrochloride Injection |
| Sponsor | Eye & ENT Hospital of Fudan University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Dexmedetomidine on Lung Protection in Elderly Patients Undergoing Laparoscopic Surgery for Colorectal Cancer (NA)
- Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia (PHASE4)
- Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke (PHASE4)
- Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia Care (PHASE1, PHASE2)
- Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients (PHASE2, PHASE3)
- ED50 of Sufentanil for Intraoperative Analgesia
- Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block (PHASE4)
- The Effects of Different Anesthetics on Functional Connectivity (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine 1μg／kg CI brief — competitive landscape report
- Dexmedetomidine 1μg／kg updates RSS · CI watch RSS
- Eye & ENT Hospital of Fudan University portfolio CI
Frequently asked questions about Dexmedetomidine 1μg／kg
What is Dexmedetomidine 1μg／kg?
Who makes Dexmedetomidine 1μg／kg?
Is Dexmedetomidine 1μg／kg also known as anything else?
What development phase is Dexmedetomidine 1μg／kg in?
Related
- Manufacturer: Eye & ENT Hospital of Fudan University — full pipeline
- Also known as: Dexmedetomidine Hydrochloride Injection
- Compare: Dexmedetomidine 1μg／kg vs similar drugs
- Pricing: Dexmedetomidine 1μg／kg cost, discount & access